Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma | Radiation Oncology | Full Text

Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma | Radiation Oncology | Full Text

Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is an extremely challenging disease with a high mortality rate and a short overall survival time. The poor prognosis can be explained by aggressive tumor growth, late di...

Authors:Q. Li, S. H. Maier, P. Li, J. Peterhansl, C. Belka, J. Mayerle and U. M. Mahajan

Citation:Radiation Oncology 2020 15:189

Content type:Review

 

Published on: 5 August 2020

• ViewFull Text
 
• ViewPDF